قالب وردپرس درنا توس
Home / Business / Johnson & Johnson Risperdal verdict: The company was awarded an $ 8 billion verdict after the drug was linked to the growth of breasts in boys

Johnson & Johnson Risperdal verdict: The company was awarded an $ 8 billion verdict after the drug was linked to the growth of breasts in boys



A jury in Philadelphia has ordered Johnson & Johnson to pay $ 8 billion in punitive damages if a man states that he developed breasts as a child after taking the company's antipsychotic Risperdal , The case has nothing to do with a series of lawsuits that the company faces because of its typical baby powder .

In the case of Risperdal, a jury found that Johnson & Johnson did not warn 26-year-old Nicholas Murray of the side effects of the drug. Murray claimed that taking Risperdal as a child led to his getting breasts, an incurable disease known as gynecomastia. Thousands of others have filed lawsuits claiming the same.

Murray was prescribed the drug at the age of 9 years for symptoms related to autism spectrum disorders, although the FDA had approved the drug in the 1

990s for the treatment of schizophrenia and episodes of bipolar adult mania.

Lawyers Murray claimed that the company had marketed the drug for unauthorized, unauthorized use in children to increase profits. Johnson & Johnson dismissed the allegations and said it was confident that the verdict would be lifted. In a statement, the company said it was "excluded from the bill … important evidence …". The company also claimed that evidence showed how the labeling of the drug "clearly and adequately outlines the risks associated with the drug".

Murray's attorneys told consumer education correspondent Anna Werner of "CBS This Morning" that punitive damages should keep the company from behaving similarly in the future. They believe that the decision remains.

© 2019 CBS Interactive Inc. All Rights Reserved.


Source link